• Home
  • XILING LAB CO.,LTD

XILING LAB CO.,LTD

About XILING LAB CO.,LTD

Xiling Lab covers full chain of pharmaceutical industry with strong background and robust capabilities. We specialize in innovative XDC platform technology (especially linker-drug systems and conjugation technology) and highly complex generic products (oncology & contrast media, star products include Eribulin Mesylate Injection and APIs of Eribulin Mesylate, Lurbinectedin, Trabectedin, Gadobutrol, Deucravacitinib, Rimegepant Sulfate). 

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2017
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • C1-805, Tianfu Life Science Park, No.88 Keyuan South Road, High-Tech Zone, 610041, Chengdu, Sichuan, China
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from XILING LAB CO.,LTD (4)

  • Eribulin Mesylate (API)

    Product Eribulin Mesylate (API)

    Generic Name: Eribulin Mesylate Injection
    Indication: Metastatic breast cancer (CN, US, EU, Japan and other countries)
    Liposarcoma (US, EU)
    Soft tissue sarcoma (Japan and other countries)

    Guidelines: 
     NCCN （2023V4）， CSCO （2023）， ESMO （2023） ...
  • Eribulin Mesylate Injection

    Product Eribulin Mesylate Injection

    Generic Name: Eribulin Mesylate Injection
    Indication: Metastatic breast cancer (CN, US, EU, Japan and other countries)
    Liposarcoma (US, EU)
    Soft tissue sarcoma (Japan and other countries)

    Guidelines: 
     NCCN （2023V4）， CSCO （2023）， ESMO （2023）

    Exc...
  • Lurbinectedin (API)

    Product Lurbinectedin (API)

    Generic Name: Lurbinectedin lyophilized powder
    Indication: Treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

    Originator: Pharma Mar
    Approval: US: June. 2020        &nbs...
  • Trabectedin (API)

    Product Trabectedin (API)

    Generic Name: Trabectedin lyophilized powder
    Indication: Treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
    Originator: Pharma Mar
    Approval: US: Oct. 2015 (Janssen) 
    Exclusivity: ODE-100 04/23

XILING LAB CO.,LTD Resources (1)

  • Brochure-Xiling Lab's Product List

    Brochure Brochure-Xiling Lab's Product List

    Xiling Lab covers full chain of pharmaceutical industry with strong background and robust capabilities. We specialize in innovative XDC platform technology (especially linker-drug systems and conjugation technology) and highly complex generic products. I am writing to seek potential opportunity of becoming your supplier (both for development and commercial stage) of our excellent oncology APIs, including Lurbinectedin, Eribulin Mesylate and Trabectedin. Please kindly find our brochure for more information.